The Adherence and LDL-C Lowering Effect of Inclisiran Among Patients Who Received Treatment at Outpatient Clinics

被引：0
|
作者：
Desai, Nihar R.
Van Hise, Nicholas
Niu, Charlene
Ghera, Elizabeth
McElligott, Sean
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Atherosclerosis; Dyslipidemia; LDL; Cholesterol-lowering drugs; Cardiovascular disease;
D O I：
10.1161/circ.148.suppl_1.16180
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16180
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The LDL-C Lowering Effect and Patient Out-of-Pocket Cost Among Patients Who Received Inclisiran Treatment at Outpatient Clinics
    Desai, Nihar
    Van Hise, Nicholas
    Niu, Xiaoli
    Ghera, Elizabeth
    Brown, Alan
    CIRCULATION, 2024, 150
  • [2] LDL-C lowering with inclisiran - a single centre experience
    Thum, C. H.
    Rosman, A.
    Choong, S. Y.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 393
  • [3] The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia
    Luo, Zhu
    Huang, Zhijun
    Sun, Feng
    Guo, Fang
    Wang, Yingying
    Kao, Sheena
    Yang, Guoping
    Huang, Jie
    Li, Jiaxin
    Zhao, Sylvia
    He, YanLing
    JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (03) : 392 - 400
  • [4] Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
    Albosta, Michael S.
    Grant, Jelani K.
    Taub, Pam
    Blumenthal, Roger S.
    Martin, Seth S.
    Michos, Erin
    VASCULAR HEALTH AND RISK MANAGEMENT, 2023, 19 : 421 - 431
  • [5] In patients with ASCVD and elevated LDL-C with maximal statin therapy, inclisiran reduced LDL-C levels at 18 months
    Clark, Jennifer
    Montori, Victor
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (04) : JC18 - JC18
  • [6] Significance of LDL-C lowering therapy in diabetic patients
    Martinez-Hervas, Sergio
    Carmena, Rafael
    Ascaso, Juan F.
    CLINICAL LIPIDOLOGY, 2011, 6 (04) : 389 - 399
  • [7] Evaluation of LDL-C reductions by siRNA treatment with inclisiran in patients with diabetes mellitus, metabolic syndrome or neither
    Wright, R. Scott
    Kallend, David
    Ray, Kausik K.
    Leiter, Lawrence
    Koenig, Wolfgang
    Raal, Frederick
    Wijngaard, Peter
    Kastelein, John J. P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [8] EVALUATION OF LDL-C REDUCTIONS BY SIRNA TREATMENT WITH INCLISIRAN IN PATIENTS WITH DIABETES MELLITUS, METABOLIC SYNDROME OR NEITHER
    Wright, R. Scott
    Kallend, David
    Ray, Kausik Kumar
    Leiter, Lawrence
    Koenig, Wolfgang
    Raal, Frederick
    Wijngaard, Peter
    Kastelein, John J. P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2005 - 2005
  • [9] Evaluation of LDL-C reductions by siRNA treatment with inclisiran in patients with diabetes mellitus, metabolic syndrome or neither
    Wright, R. Scott
    Kallend, David
    Ray, Kausik K.
    Leiter, Lawrence
    Koenig, Wolfgang
    Raal, Frederick
    Wijngaard, Peter
    Kastelein, John J. P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [10] EFFECT OF INCLISIRAN ON LDL-C REDUCTION ACROSS DIFFERENT BACKGROUND LIPID LOWERING TREATMENTS: ANALYSES FROM ORION-11
    Ray, Kausik Kumar
    Kallend, David
    Leiter, Lawrence
    Raal, Frederick
    Koenig, Wolfgang
    Wright, Scott
    Wijngaard, Peter
    Kastelein, John J. P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2078 - 2078
12345